The use cases of medical chatbots have grown considerable over the past few decades. Healthcare delivery organizations have ramped up investments in bosting their AI capabilities, given the role of AI in patient self-management and the use of digital personal assistants for primary care. Since the mainstreaming of first chatbot, ELIZA, the usability, speed, and performance of healthcare chatbots have increased significantly. State-of-the art methods of machine learning have further expanded the scope of the emerging technology in the healthcare chatbots market. The role of the healthcare chatbots in reducing load of primary care is one of the key market propositions.
The evolving paradigm of e-health has shaped the growth trajectories of the global healthcare chatbots market. Extensive study has been done to evaluate the impacts of these chatbots on clinical outcomes. Subsequently, there has been a spate of venture capital fundings on developing AI-powered conversational solutions. The study on the healthcare chatbots market presents a detailed assessment of key growth dynamics, promising customer propositions, avenues in various geographies, and profiling of the top incumbent players and strategies of new entrants.
The rapid penetration of smartphones among clinicians, patients, and caregivers has spurred web-based interventions, and thus has propelled the commercialization scope of products in the healthcare chatbots market. Healthcare IT companies have unveiled several interactive chatbots, thereby enriching the landscape. Stridently, installation of chat apps has also soared. Consequently, the potential healthcare benefits of these chatbots have also increased.
Healthcare chatbots hold high potential in mental health and chronic health conditions. The use of healthcare chatbots for managing diabetes. Tech companies developing chatbots have aimed at high-quality human-machine interactions to boost engagement between payers, providers, and patients in the healthcare industry. Physicians, nurses, patients, and caregivers find healthcare chatbots in various areas such as medication management, emergency care, and numerous areas of patient pathways. The focus on launching personalized products is likely to spur patients to install the apps.
Companies have been trying new approaches to develop smarter healthcare chatbots especially that offers a more natural experience comparable to what is expected to trained clinician. Meanwhile, healthcare providers are deploying chatbots for various diagnostic needs.
Northwell Health, a New York-based healthcare provider, has unveiled healthcare chatbots to educate patients on colonoscopies—inform them about the procedure, misconceptions, and potential factors—which eventually has sought to reduce ‘no shows’. This thus is helping them exhort patients not to skip the procedure, thereby boosting colorectal cancer diagnosis.
Another New York-headquartered healthcare company OneRemission have launched healthcare apps for meet all information needs of cancer patients and cancer survivors, notably pertaining to their diets, exercises, and others post-cancer care. The commercialization of such products in the healthcare chatbots market have helped reduce the burden on primary care. In recent times, healthcare chatbots have been attracting patients and physicians for their promise of getting AI consultations as well as scheduling an appointment with the doctor based on medical history and live video consultations.
Asia Pacific is expected to hold vast revenue potential, given the growing attractiveness of apps in e-health. North America has witnessed substantial opportunities being capitalized by players in the global healthcare chatbots market. Several companies in the healthcare IT domain have been leaning on unveiling more interactive bots. Additionally, a few of the healthcare providers have reaped massive revenue gains from the clinical effectiveness of these in mental health and chronic diseases. The entry of start-ups with massive VC funding has further bolstered the prospects of healthcare chatbots in the North America healthcare chatbots market.